Evidence map›Paper›PMID 41225641›Full record

ArticleCell & bioscience2025

Single-cell transcriptome analysis profiles the enlarged subsets of myeloid-biased HSPCs with preleukemic characters in disuse osteoporosis mice.

Chen Zhang, Yueru Ji, Xiaotong Gao, Zhuo Wan, Fangna Gu, Dian Lou, Han Liang, Li Liu, Weiwei Qin

Abstract read
In one paragraph

Article in Cell & bioscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chen Zhang *Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xinsi Road 569, Tangdu Hospital, Baqiao District, Xi'an, 710038, Shannxi, China. chenzhangbio@163.com.ORCID http://orcid.org/0000-0001-8576-818X
Yueru Ji *Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xinsi Road 569, Tangdu Hospital, Baqiao District, Xi'an, 710038, Shannxi, China.
Xiaotong Gao *Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xinsi Road 569, Tangdu Hospital, Baqiao District, Xi'an, 710038, Shannxi, China.
Zhuo WanDepartment of Hematology, Tangdu Hospital, Fourth Military Medical University, Xinsi Road 569, Tangdu Hospital, Baqiao District, Xi'an, 710038, Shannxi, China.
Fangna GuDepartment of Hematology, Tangdu Hospital, Fourth Military Medical University, Xinsi Road 569, Tangdu Hospital, Baqiao District, Xi'an, 710038, Shannxi, China.
Dian LouDepartment of Hematology, Tangdu Hospital, Fourth Military Medical University, Xinsi Road 569, Tangdu Hospital, Baqiao District, Xi'an, 710038, Shannxi, China.
Han LiangLife Sciences and Medicine of Air Force Medical University, Xi'an, 710038, Shannxi, China.
Li LiuDepartment of Hematology, Tangdu Hospital, Fourth Military Medical University, Xinsi Road 569, Tangdu Hospital, Baqiao District, Xi'an, 710038, Shannxi, China. heamatol@fmmu.edu.cn.
Weiwei QinDepartment of Hematology, Tangdu Hospital, Fourth Military Medical University, Xinsi Road 569, Tangdu Hospital, Baqiao District, Xi'an, 710038, Shannxi, China. vivianq1126@126.com.

Funding

National Natural Science Foundation of China 82200171Yinfeng Plan of Tangdu hospital 2021YFJH009
6 · The paper itself

Abstract

backgroundOsteoporosis (OP) could lead to the alteration of bone marrow microenvironment and non-homeostasis of hematopoiesis, which could increase the incidence of hematologic malignancies. However, whether myeloid-biased hematopoiesis occurred and contributed to the leukemogenesis under the condition of OP remains unclear.

resultsThis study successfully induced a mouse model for OP by hindlimb unloading, which shows increased myeloid cells and decreased B cells in the peripheral blood (PB). Furthermore, our study demonstrates that the myeloid-biased subset of HSPCs (hematopoietic stem and progenitor cells) with reduced differentiation and apoptosis, including multipotent progenitor 3 (MPP3) and granulocyte-monocyte progenitors (GMPs), were expanded in the OP mice. The expansion of myeloid-biased HSPCs contributes to the accumulation of HSPCs in the bone marrow and increased myeloid cells in the PB of OP mice. In the expanded pool of HSPCs, OP mice specifically enriched subsets were identified and profiled by single cell RNA-seq, including subHSCs from primitive HSCs, MPP3-1 from MPP3, GMP5 from GMPs, MkP2 from megakaryocyte progenitors and EryP1 from erythrocyte progenitors. Meanwhile, those OP-HU mice enriched subsets shared significantly up- and down-regulated genes enriched in chromatin modification and cell differentiation and apoptosis such as Bromodomain-containing protein 4 (Brd4), encoding an important chromatin remodeling protein, and Proteinase 3 (Prtn3). Moreover, the specific transcription factors corresponding to the expansion of subHSCs, MPP3-1, GMP5 and EryP1 in OP-HU mice were identified as Zfp951, Nfic, Maz and Ezh2. Finally, inhibition of BRD4 in vivo could partially restore the phenotype of OP-HU mice and the expression of genes regulating HSPC expansion, differentiation and apoptosis.

conclusionsFirst of all, our study shows that OP could induce the unbalanced hematopoiesis and enhances the myeloid-biased hematopoiesis. Secondly, OP mice enriched subsets of HSPCs were identified and characterized with enhanced chromatin remodeling, reduced differentiation and resistance to apoptosis. Finally, this study demonstrate that Brd4 regulated gene programs endow the myeloid-biased subsets of HSPCs with tumor cell-like characters in OP mice, which may increase the incidence of the leukemic evolution. This study sheds light on the importance for the prevention of myeloid leukemogenesis in human with OP.

Indexed as

Brd4HematopoiesisLeukemogenesisMyeloid-biasedOsteoporosis

Identifiers

PMID41225641
PMCPMC12607142

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.